Diaphragmatic hernia during treatment of lung cancer harboring an EGFR mutation

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are a first-line treatment for patients with nonsmall-cell lung cancer harboring EGFR mutations. We report a 65-year-old Japanese woman with nonsmall-cell lung cancer taking an EGFR-TKI who visited the emergency department wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Konno-Yamamoto, Aya, Narumoto, Osamu, Yamamoto, Shota, Yamaguchi, Miho, Motoyoshi, Makoto, Inoue, Yuta, Fukami, Takeshi, Tamura, Atsuhisa, Matsui, Hirotoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297640/
https://www.ncbi.nlm.nih.gov/pubmed/34306720
http://dx.doi.org/10.1093/omcr/omab054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297640/
https://www.ncbi.nlm.nih.gov/pubmed/34306720
http://dx.doi.org/10.1093/omcr/omab054

Ejemplares similares